Preoperative treatment with tegafur suppositories enhances apoptosis and reduces the intratumoral microvessel density of human colorectal carcinoma

Cancer

Volumn 88, Issue 5, 2000, Pages 1007-1015

  Matsuura, Takahiko ^a   Fukuda, Yasuhiko ^b   Fujitaka, Tsuruo ^b   Nishisaka, Takashi ^b   Sakatani, Takashi ^a   Ito, Hisao ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b HIROSHIMA PREFECTURAL HOSPITAL   (Japan)

Author keywords

Angiogenesis; Apoptosis; Colorectal carcinoma; p53 gene; Tegafur suppository

Indexed keywords

CD34 ANTIGEN; KI 67 ANTIGEN; PROTEIN BAX; PROTEIN P21; PROTEIN P53; TEGAFUR; THYMIDINE PHOSPHORYLASE; VASCULOTROPIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL; CELL PROLIFERATION; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRUG ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPPOSITORY; TUMOR VASCULARIZATION;

AGED; AGED, 80 AND OVER; ANTIGENS, CD34; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; COLORECTAL NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KI-67 ANTIGEN; LYMPHOKINES; MALE; MICROCIRCULATION; MIDDLE AGED; PREOPERATIVE CARE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SUPPOSITORIES; TEGAFUR; THYMIDINE PHOSPHORYLASE; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034161643     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000301)88:5<1007::AID-CNCR9>3.0.CO;2-6     Document Type: Article

References (37)

1. Parker WB, Cheng YC. Metabolism and mechanism of action of 5-fluorouracil. Pharmacol Ther 1990;48:381-95.
2. Nabeya Y, Loganzo F Jr., Maslak P, Lai L, de Oliveira AR, Schwartz GK, et al. The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents. Int J Cancer 1995;64: 37-46.
3. Pickard M, Dive C, Kinsella AR. Differences in resistance to 5-fluorouracil as a function of cell cycle delay and not apoptosis. Br J Cancer 1995;72:1389-96.
4. Osaki M, Tatebe S, Goto A, Hayashi M, Oshimura M, Ito H. 5-fluorouracil (5-FU) induced apoptosis in gastric cancer cell lines: role of the p53 gene. Apoptosis 1997;2:221-6.
5. Kieser A, Weich HA, Brander G, Marmé D, Kolch W. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 1994;9:963-9.
6. Takahashi T, Kohno K, Yamaguchi T, Narisawa T. Preoperative use of 5-fluorouracil suppository for carcinoma of the rectum. Am J Surg 1982;143:183-5.
7. Takahashi T, Mizusawa H, Kato T, Yamaguchi T. Preoperative irradiation and 5-fluorouracil suppository for carcinoma of the rectum. Am J Surg 1988;156:58-62.
8. Takahashi T, Horie H, Kojima O, Itoh M. Preoperative combined treatment with radiation, intraluminal hyperthermia, and 5-fluorouracil suppositories for patients with rectal cancer. Surg Today 1993;23:1043-8.
9. Makino M, Shirai H, Sugamura K, Kimura O, Maeta M, Ito H, et al. Increased induction of apoptosis of human colorectal cancer cells after preoperative treatment with 5-fluorouracil. Oncol Rep 1996;3:281-5.
10. Sugamura K, Makino M, Shirai H, Kimura O, Maeta M, Ito H, et al. Enhanced induction of apoptosis of human gastric carcinoma cells after preoperative treatment with 5-fluorouracil. Cancer 1997;79:12-7.
11. Oki E, Sakaguchi Y, Toh Y, Oda S, Maehara Y, Yamamoto N, et al. Induction of apoptosis in human tumour xenografts after oral administration of uracil and tegafur to nude mice bearing tumours. Br J Cancer 1998;78:625-30.
12. Yamane N, Makino M, Kaibara N. S-phase accumulation precedes apoptosis induced by preoperative treatment with 5-fluorouracil in human colorectal carcinoma cells. Cancer 1999;85:309-17.
13. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991;34: 424-5.
14. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
15. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
16. Kerr JF. Shrinkage necrosis: a distinct mode of cellular death. J Pathol 1971;105:13-20.
17. Kasagi N, Gomyo Y, Shirai H, Tsujitani S, Ito H. Apoptotic cell death in human gastric carcinoma: analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling. Jpn J Cancer Res 1994;85:939-45.
18. Tatebe S, Ishida M, Kasagi N, Tsujitani S, Kaibara N, Ito H. Apoptosis occurs more frequently in metastatic foci than in primary lesions of human colorectal carcinomas: analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling. Int J Cancer 1996;65:173-7.
19. Ishida M, Gomyo Y, Tatebe S, Ohfuji S, Ito H. Apoptosis in human gastric mucosa, chronic gastritis, dysplasia and carcinoma: analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling. Virchows Arch 1996;428:229-35.
20. Ishida M, Gomyo Y, Ohfuji S, Ikeda M, Kawasaki H, Ito H. Evidence that expression of a mutated p53 gene attenuates apoptotic cell death in human gastric intestinal-type carcinomas in vivo. Jpn J Cancer Res 1997;88:468-75.
21. Ikeda M, Shomori K, Endo K, Makino T, Matsuura T, Ito H. Frequent occurrence of apoptosis is an early event in the oncogenesis of human gastric carcinoma. Virchows Arch 1998;432:43-7.
22. Kasagi N, Adachi H, Ueno E, Hayashi H, Ito H. Initial phase of apoptosis detected by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling in UV-irradiated HL-60 cells: morphological and biochemical findings of DNA fragmentation. Biochem Res 1996;17:385-93.
23. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993;362:847-9.
24. Lowe SW, Ruley HE, Jack T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993;74:957-67.
25. Waldmann T, Kinzler KW, Vogelstein B. p21 necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res 1995;55:5187-90.
26. El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canmann CE, Jackman J, et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994;54:1169-74.
27. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995; 80:293-9.
28. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-19.
29. Fritsche M, Haessler C, Brandner G. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 1993;8:307-18.
30. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-9.
31. Berse B, Brown LF, Van de Water L, Dvorak HF, Senger DR. Vascular permeabillity factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 1992;3:211-20.
32. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992;255:989-91.
33. Takahashi Y, Tucker SL, Kitadai Y, Koura AN, Bucana CD, Cleary KR, et al. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg 1997;132:541-6.
34. Kang SM, Maeda K, Onoda N, Chung YS, Nakata B, Nishiguchi Y, et al. Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis. Int J Cancer 1997;74:502-7.
35. Yamamoto S, Yasui W, Kitadai Y, Yokozaki H, Haruma K, Kajiyama G, et al. Expression of vascular endothelial growth factor in human gastric carcinomas. Pathol Int 1998;48:499-506.
36. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, et al. Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br J Cancer 1996;73:884-8.
37. Takebayashi Y, Akiyama S, Akiba S, Yamada K, Miyadera K, Sumizawa T, et al. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 1996;88: 1110-7.